about
Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A(2)sCloning and recombinant expression of a structurally novel human secreted phospholipase A2Effect of phospholipase A2 inhibitory peptide on inflammatory arthritis in a TNF transgenic mouse model: a time-course ultrastructural studyRNA-mediated neurodegeneration in fragile X-associated tremor/ataxia syndromePhospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic interventionCrystal structure of human group X secreted phospholipase A2. Electrostatically neutral interfacial surface targets zwitterionic membranesD-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activityStructural Characterization of Myotoxic Ecarpholin S From Echis carinatus VenomThe transfer of VLDL-associated phospholipids to activated platelets depends upon cytosolic phospholipase A2 activityFcgamma RI-triggered generation of arachidonic acid and eicosanoids requires iPLA2 but not cPLA2 in human monocytic cellsPhospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizationsStimulation of arachidonic acid release by vasopressin in A7r5 vascular smooth muscle cells mediated by Ca2+-stimulated phospholipase A2On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymesMolecular basis of phospholipase A2 activity toward phospholipids with sn-1 substitutions.Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death.Functional site of endogenous phospholipase A2 inhibitor from python serum.Hypotonic cell swelling induces translocation of the alpha isoform of cytosolic phospholipase A2 but not the gamma isoform in Ehrlich ascites tumor cells.Localization of group V phospholipase A2 in caveolin-enriched granules in activated P388D1 macrophage-like cells.Arachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A(2) occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A(2)-alpha.Cloning and characterization of the DNA region responsible for Megacin A-216 production in Bacillus megaterium 216Cytosolic phospholipase A2: a member of the signalling pathway of a new G protein alpha subunit in Sporothrix schenckii.The role of neutrophils in the event of intestinal inflammationDrug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework.The role of calcium-independent phospholipase A2 in cardiolipin remodeling in the spontaneously hypertensive heart failure rat heartRole of calcium-independent phospholipase A2beta in high glucose-induced activation of RhoA, Rho kinase, and CPI-17 in cultured vascular smooth muscle cells and vascular smooth muscle hypercontractility in diabetic animals.Bioactive sesterterpenes and triterpenes from marine sponges: occurrence and pharmacological significancePhospholipase A2 enzymes in eicosanoid generation.Phospholipase A2 in eicosanoid generation.Modulation of cell-substrate adhesion by arachidonic acid: lipoxygenase regulates cell spreading and ERK1/2-inducible cyclooxygenase regulates cell migration in NIH-3T3 fibroblasts.Acanthamoeba-cytopathic protein induces apoptosis and proinflammatory cytokines in human corneal epithelial cells by cPLA2α activation.Impacts of cytosolic phospholipase A2, 15-prostaglandin dehydrogenase, and cyclooxygenase-2 expressions on tumor progression in colorectal cancer.The binding mode of cladocoran A to the human group IIA phospholipase A(2).Inhibition of Ca2+-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance.Relationship between a common variant in the fatty acid desaturase (FADS) cluster and eicosanoid generation in humans.Antioxidant and gastric cytoprotective prostaglandins properties of Cassia sieberiana roots bark extract as an anti-ulcerogenic agent.Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells.Group VIA phospholipase A2 in both host and tumor cells is involved in ovarian cancer development.MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles.Choline-containing phospholipids in microdissected human Alzheimer's disease brain senile plaque versus neuropil.The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells.
P2860
Q22253225-73662BB0-E985-4514-9E47-5B0DB1AF8E8FQ24290406-88609E68-FCB2-4089-87AC-30915DD356BDQ24801037-E6E699F9-280B-4938-B419-4A3BF68A5534Q26992035-BB67D72E-27D6-4B86-BAA9-043525777F02Q26997377-A0D16E8F-4EAB-4AAD-A86D-9896EAD83A52Q27639454-94303BC6-E3B1-497B-9255-1D70A2A6E791Q27640620-ED0806EA-3DDD-4D39-BEC5-D1926DC70FA9Q27650993-70862D45-3C87-4998-87CA-6DB5D5D50446Q28222505-E5D1EEE0-5567-491B-93FE-09C81D224407Q28248992-5B65AD47-B5FD-4AE3-8A7C-C0BCE226065EQ28286551-37B02A77-194D-48D5-A9C8-DC3E3EB207CCQ28568272-5C4B9C67-7B2A-4BB1-B927-0D2CE9F23648Q28592582-0BE70B13-E695-4ABD-8156-523055642A74Q30440522-2465E881-AB6E-4E1F-942F-A3D35FDE4B17Q30484548-BE4E0E7A-2D21-4BC5-82F3-B1F028B5B257Q30724983-A0DBD77B-4B7B-4010-ABB5-A60AC006C530Q30908259-473B8D56-2101-469A-A7BB-1004E46656EEQ31156335-400D2FDB-4AEE-4EC9-968A-1372750A41B6Q33199057-41C8ADBE-4BDA-4181-9A32-ED2D8F3DA7C7Q33358766-5AED7178-3C73-41FF-A418-00936E5F5605Q33447956-34326C32-07F6-4F38-A08E-D310456113AFQ33557524-1CACEC41-CD64-478C-8E86-ED8BFD34DF54Q33597328-78AFD1A5-D924-4E01-BD20-F23DE5200103Q33634137-DD4F12D4-3E69-45B7-B054-BF947B17AB7BQ33726396-601D8CCC-B78E-4A68-AA09-9E18D34B1F7EQ33782130-CB7BA1F8-09AA-494A-870D-D4D3F714AE44Q33790580-FB85F57F-2A40-4CB3-B882-0653FD9B0564Q33836689-C22FA2CB-43B4-4787-94C9-A4E1C1AB58CBQ33937217-2924832D-4BC2-41E1-859F-CB2900CE8411Q33961127-69F1828C-A853-4CFF-BF81-482A4CFB4687Q34015084-EEDED764-4003-46AF-A9B8-0C4AF8E86AC2Q34033380-D43064B6-D04E-4DC1-A7A5-A513037286A4Q34050555-550B5070-EC72-4251-93E6-8ECFFB3BAB34Q34070498-DE0A32F7-1D82-41CE-925A-A46C7B8220D2Q34274682-55E75ACA-242F-4CCA-AB44-3D9D6A26D216Q34353322-D11325B8-E0A9-4101-BB50-E0CEFBB04721Q34378792-79763DC5-A0C1-4A1C-B548-64825996A8AFQ34387277-8A71002C-D394-4FAC-84BB-39DE18DEEE01Q34421898-34C5458F-6549-4C8F-A962-050B14862DB2Q34676329-E2F482FB-1D1A-46C1-B4EB-537D498A2A44
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Regulation and inhibition of phospholipase A2.
@ast
Regulation and inhibition of phospholipase A2.
@en
type
label
Regulation and inhibition of phospholipase A2.
@ast
Regulation and inhibition of phospholipase A2.
@en
prefLabel
Regulation and inhibition of phospholipase A2.
@ast
Regulation and inhibition of phospholipase A2.
@en
P50
P1476
Regulation and inhibition of phospholipase A2
@en
P2093
P304
P356
10.1146/ANNUREV.PHARMTOX.39.1.175
P577
1999-01-01T00:00:00Z